Efficacy of Oral Famotidine in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2

Introduction The clinical benefit of famotidine has been observed in the management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, its use in the management of SARS-CoV-2 is intriguing and not well established yet. In this study, we aimed to determine the role of famotidin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahwani, Suraksha, Kumar, Mahesh, Aperna, FNU, Gul, Mehak, Lal, Darshan, Rakesh, FNU, Shabbir, Muhammad Raffey, Rizwan, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942052/
https://www.ncbi.nlm.nih.gov/pubmed/35345695
http://dx.doi.org/10.7759/cureus.22404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942052/
https://www.ncbi.nlm.nih.gov/pubmed/35345695
http://dx.doi.org/10.7759/cureus.22404

Ejemplares similares